SRTA - Strata Critical Medical, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$7.25
DETAILS
HIGH:
$7.25
LOW:
$7.25
MEDIAN:
$7.25
CONSENSUS:
$7.25
UPSIDE:
35.14%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 20.9% |
| EBIT Margin | -11.3% |
| EBITDA Margin | -7.2% |
| Operating Margin | -11.3% |
| Pretax Margin | -10.2% |
| Cont. Ops Margin | -10.2% |
| Net Margin | 21.0% |
| Bottom Line Margin | 21.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 6.38 |
| Quick Ratio | 6.38 |
| Solvency Ratio | 1.067 |
| Cash Ratio | 1.56 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-25.32
Peers avg: 30.8
|
| PEG Ratio | 0.55 |
| Forward PEG | 0.55 |
| Price/Book | 1.42 |
| Price/Sales | 2.01 |
| Price/FCF | -6.62 |
| Price/Op Cash Flow | -8.11 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0102 |
| Debt/Equity | 0.0118 |
| Debt/Capital | 0.0117 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.17 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.61 |
| Operating Cash Flow Ratio | -2.471 |
| Operating Cash Flow/Sales | -24.8% |
| Free Cash Flow/Operating Cash Flow | 122.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -14.79 |
| Capital Expenditure Coverage | -4.44 |
| Dividend + Capital Expenditure Coverage | -4.44 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.39 |
| EPS | 0.501 |
| Debt/Share | 0.0401 |
| Cash/Share | 0.74 |
| Book Value/Share | 3.38 |
| Tangible BV/Share | 1.74 |
| Equity/Share | 3.38 |
| Operating Cash Flow/Share | -0.593 |
| Capital Expenditure/Share | 0.134 |
| FCF/Share | -0.727 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | -2.061 |
| Earnings Before Tax/EBIT | 0.898 |
| Price/Fair Value | 1.42 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -26.04 |